by Ben Vernia | September 30th, 2014
On September 29, the Office of Inspector General of HHS announced that it had reached a settlement for nearly $146,000 with a Connecticut lab over allegations the company bypassed urine test reimbursement limits in Medicare. According to OIG-HHS’s announcement:
Clinical Lab Partners (CLP), a laboratory in Newington, CT, that performed urine drug testing, agreed to enter into a $145,789.34 settlement agreement with the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services effective September 29, 2014. The settlement resolves allegations CLP submitted false or fraudulent claims to Medicare. Specifically, OIG contends CLP submitted claims to Medicare for high complexity urine drug tests exceeding the number of units allowed by Medicare by using a code to bypass computer programming that would have otherwise rejected such claims. OIG’s Office of Audit Services and Office of Counsel to the Inspector General, represented by Senior Counsels Andrea Treese Berlin and Geoff Hymans, collaborated to achieve this settlement.
